| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.35▲ | 10.36▲ | 10.40▼ | 11.33▼ | 12.27▼ |
| MA10 | 10.33▲ | 10.50▼ | 10.55▼ | 12.18▼ | 11.45▼ |
| MA20 | 10.49▼ | 10.78▼ | 10.94▼ | 12.52▼ | 11.18▼ |
| MA50 | 10.95▼ | 11.47▼ | 11.81▼ | 11.44▼ | 15.73▼ |
| MA100 | 11.48▼ | 12.19▼ | 12.49▼ | 11.58▼ | N/A |
| MA200 | 11.95▼ | 12.62▼ | 12.36▼ | 15.36▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.024▲ | -0.009▼ | -0.018▼ | -0.371▼ | 0.404▲ |
| RSI | 38.913▼ | 30.299▼ | 28.233▼ | 36.523▼ | 42.809▼ |
| STOCH | 51.699 | 18.269▼ | 14.616▼ | 9.417▼ | 52.173 |
| WILL %R | -55.882 | -67.626 | -82.955▼ | -90.971▼ | -70.886 |
| CCI | -5.356 | -72.523 | -82.717 | -166.787▼ | -1.862 |
|
Friday, August 08, 2025 03:30 AM
Second Quarter 2025 Results Key Financial Results Net income: US$15.9m (up ...
|
|
Friday, August 08, 2025 01:29 AM
GAAP revenue for Q2 2025 dropped 99.1% from last year to $0.298 million. The pivotal Phase 3 AURORA trial for Descartes-08 in myasthenia gravis started enrolling patients.
|
|
Friday, August 01, 2025 05:22 AM
Q2 2025 Earnings Call Transcript July 31, 2025 Ferrari N.V. beats earnings expectations. Reported EPS is $2.7, expectations were $2.57. Operator: Good day, and thank you for standing by. Welcome to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/08/25 | 10.51 | 10.8254 | 10.13 | 10.53 | 32,141 |
| 07/08/25 | 11.45 | 11.82 | 10.40 | 10.54 | 48,094 |
| 06/08/25 | 11.79 | 11.82 | 11.09 | 11.28 | 58,369 |
| 05/08/25 | 12.54 | 12.57 | 11.70 | 11.83 | 65,487 |
| 04/08/25 | 12.43 | 12.48 | 12.02 | 12.48 | 27,417 |
| 01/08/25 | 12.56 | 13.10 | 12.06 | 12.33 | 77,855 |
| 31/07/25 | 12.66 | 13.21 | 12.50 | 12.81 | 89,497 |
| 30/07/25 | 13.40 | 13.9599 | 12.70 | 12.85 | 84,986 |
| 29/07/25 | 13.59 | 13.815 | 13.26 | 13.40 | 36,085 |
| 28/07/25 | 13.43 | 14.56 | 13.43 | 13.70 | 54,617 |
|
|
||||
|
|
||||
|
|